Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Products>This Product

F1-ClipTip™ Pipetting System

Product Image
Product Description

You’ll feel the difference the first time you hold the NEW Thermo Scientific™ F1-ClipTip™ pipetting system. 

Thermo-Absolute-border.gifObtaining the correct sample volume is often the first step in a series that your research requires, and it is a challenge to ensure a quality seal in daily pipetting. The ClipTip interlocking technology lets you actually feel the tips lock firmly in place with a light touch and ensures you have a complete seal for each channel.

Whether you’re using a single or multichannel pipette, you will get the exact volume you expect to accelerate discovery. No longer bang tips on your pipette. Your friction based pipetting system might look like tips are on, but how certain are you?

No more uncertainty – just confidence in your applications. Worry-free pipetting is finally here, with the only tip that clips.

Friction Seal Systems are dependent on a user’s force to attach tips to the pipette
  • Increased tip attachment and ejection forces
  • Loose tips which can drop off or leak air
  • Decreased confidence in reproducibility of results
  • Premature tip cone wear
ClipTip Interlocking Technology utilizes a locking interface between the pipette fitting and tips that seal by clipping into place.
  • Extremely low tip attachment and ejection forces
  • Complete seal on every channel
  • No loose tips
  • Reproducibility you can count on
Learn more or download our application notes: Thermo Scientific™ F1-ClipTip™
Product F1-ClipTip™ Pipetting System
Company Thermo Fisher Scientific
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Thermo Fisher Scientific
355 River Oaks Pkwy San Jose, CA 95134 USA

Tel: 1-800-532-4752


Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos